Pancreatic Cancer Trial, Recruiting NCT00912717 Sponsor: University of Pittsburgh Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT00912717
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer), either confirmed by tissue sample or by a CT scan
  • People who have an abnormal result on an imaging scan of the pancreas area (such as a CT, MRI, or similar scan)
  • People who have been clinically diagnosed with a condition affecting the pancreas, liver, or intestines
  • People who have been diagnosed with acute pancreatitis (sudden inflammation of the pancreas)
  • People who have been diagnosed with chronic pancreatitis (long-term inflammation of the pancreas)
  • People who have been diagnosed with a blockage in the bile ducts
  • People who have been diagnosed with a cyst on the pancreas
  • People who have at least one close family member who has had pancreatic cancer
  • Healthy people who do not have any of the conditions listed above

Who may not be able to join:

  • People who are under 18 years of age
  • People who are not able to give their own informed consent to participate
  • People who are not able to travel to Pittsburgh in person to enrol in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Randall E Brand, MD, University of Pittsburgh

Phone: 412-623-3105

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2004
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The data will be used in cohort association studies. Endpoints will depend on the number of patients in the study and the number of markers that are being evaluated.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov